Literature DB >> 16430206

Interactions of granisetron with an agonist-free 5-HT3A receptor model.

Prasad R Joshi1, Asha Suryanarayanan, Eszter Hazai, Marvin K Schulte, Gábor Maksay, Zsolt Bikádi.   

Abstract

A new homology model of type-3A serotonin receptors (5-HT(3A)Rs) was built on the basis of the electron microscopic structure of the nicotinic acetylcholine receptor and with an agonist-free binding cavity. The new model was used to re-evaluate the interactions of granisetron, a 5-HT(3A)R antagonist. Docking of granisetron identified two possible binding modes, including a newly identified region for antagonists formed by loop B, C, and E residues. Amino acid residues L184-D189 in loop B were mutated to alanine, while Y143 and Y153 in loop E were mutated to phenylalanine. Mutation H185A resulted in no detectable granisetron binding, while D189A resulted in a 22-fold reduction in affinity. Y143F and Y153F decreased granisetron affinity to the same extent as Y143A and Y153A mutations, supporting the role of the OH groups of these tyrosines in loop E. Modeling and mutation studies suggest that granisetron plays its antagonist role by hindering the closure of the back wall of the binding cavity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16430206     DOI: 10.1021/bi051676f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptor.

Authors:  M Lochner; S C R Lummis
Journal:  Biophys J       Date:  2010-04-21       Impact factor: 4.033

2.  Improved surface modification approach for micromechanical biosensors.

Authors:  Hongyan Gao; Koutilya R Buchapudi; Abraham Harms-Smyth; Marvin K Schulte; Xiaohe Xu; Hai-Feng Ji
Journal:  Langmuir       Date:  2007-12-22       Impact factor: 3.882

Review 3.  Allosteric modulation of glycine receptors.

Authors:  Gonzalo E Yevenes; Hanns Ulrich Zeilhofer
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

4.  Mapping spatial relationships between residues in the ligand-binding domain of the 5-HT3 receptor using a molecular ruler.

Authors:  Heather L Nyce; Spencer T Stober; Cameron F Abrams; Michael M White
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

Review 5.  Therapeutics of 5-HT3 receptor antagonists: current uses and future directions.

Authors:  Tina K Machu
Journal:  Pharmacol Ther       Date:  2011-02-26       Impact factor: 12.310

6.  Ondansetron and granisetron binding orientation in the 5-HT(3) receptor determined by unnatural amino acid mutagenesis.

Authors:  Noah H Duffy; Henry A Lester; Dennis A Dougherty
Journal:  ACS Chem Biol       Date:  2012-08-15       Impact factor: 5.100

7.  Molecular interactions between general anesthetics and the 5HT2B receptor.

Authors:  Felipe Matsunaga; Lu Gao; Xi-Ping Huang; Jeffery G Saven; Bryan L Roth; Renyu Liu
Journal:  J Biomol Struct Dyn       Date:  2013-12-23

Review 8.  The 5-HT3 receptor--the relationship between structure and function.

Authors:  Nicholas M Barnes; Tim G Hales; Sarah C R Lummis; John A Peters
Journal:  Neuropharmacology       Date:  2008-08-12       Impact factor: 5.250

9.  Approaching the 5-HT₃ receptor heterogeneity by computational studies of the transmembrane and intracellular domains.

Authors:  Marta Del Cadia; Francesca De Rienzo; Maria Cristina Menziani
Journal:  J Comput Aided Mol Des       Date:  2013-06-16       Impact factor: 3.686

10.  Loop B is a major structural component of the 5-HT3 receptor.

Authors:  A J Thompson; M Lochner; S C R Lummis
Journal:  Biophys J       Date:  2008-10-17       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.